XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 12, 2023
Dec. 11, 2023
Product Information [Line Items]              
Net loss $ 1,384,804   $ (6,768,355)        
Assets 73,614,333     $ 72,460,026      
Liabilities 74,007,087     76,505,394      
Revenue performance obligation $ 3,900,000            
Subscription price per share $ 1.95            
Deferred revenue $ 14,600,000     14,500,000      
Deferred revenue       12,700,000      
Sales returns and allowances 832,000     894,000      
Inventory reserve 153,464     263,320      
Deposits assets, current 191,840     40,763      
Purchase obligation 279,000            
Capitalized software costs $ 14,311,592     $ 13,816,501      
Fulfillment Services [Member] | Supplier Concentration Risk [Member] | Vendors [Member]              
Product Information [Line Items]              
Concentration risk percentage 65.00%     80.00%      
Prescription Medications [Member] | Supplier Concentration Risk [Member] | Vendors [Member]              
Product Information [Line Items]              
Concentration risk percentage 20.00%            
Minimum [Member]              
Product Information [Line Items]              
Percentage of interest-bearing domestic deposits 10.00%            
Intangible assets, term 1 year            
Maximum [Member]              
Product Information [Line Items]              
Percentage of interest-bearing domestic deposits 33.00%            
Intangible assets, term 10 years            
Product [Member]              
Product Information [Line Items]              
Customer discounts and allowance $ 776,000   991,000        
Software Revenue [Member]              
Product Information [Line Items]              
Customer discounts and allowance 1,100,000   766,000        
TeleHealth in Process [Member]              
Product Information [Line Items]              
Accrued contract liabilities 10,100,000     $ 10,100,000      
Accrued contract liabilities 2,000,000.0     1,900,000      
WorkSimpli in Process [Member]              
Product Information [Line Items]              
Accrued contract liabilities 2,500,000     2,500,000      
LifeMD PC [Member]              
Product Information [Line Items]              
Net loss 3,300,000   2,400,000        
Assets 7,000     8,000      
Liabilities $ 201,000     380,000      
Medifast Inc [Member]              
Product Information [Line Items]              
Transaction amount       $ 10,000,000   $ 5,000,000 $ 10,000,000
Consideration to be transferred   $ 2,500,000 2,500,000        
Transaction amount collected   $ 3,000,000 $ 2,000,000   $ 5,000,000